Скачать или смотреть Indian Pharma wants to Conquer Cancer | The Daily Brief

In today's episode of The Daily Brief, we cover 2 major stories shaping the Indian economy and global markets:

1. Indian Pharma’s Fight Against Cancer
India’s pharmaceutical industry is betting big on oncology drugs, especially biosimilars, to make advanced cancer treatments more affordable. Companies like Biocon, Glenmark, Dr. Reddy’s, and Zydus are investing heavily in biologics and partnerships to challenge expensive Western drugs. Despite hurdles like trial infrastructure and patent issues, India aims to become a global hub for cancer therapies.

2. RBI Cracks Down on Simpl
The RBI has ordered BNPL startup Simpl to halt all payment operations, accusing it of running a payment system without proper authorization. This move comes as regulators tighten rules on fintech players handling money flows. Simpl now faces tough choices: partner with licensed aggregators, apply for its own license, or pivot its business model entirely.

Timestamps:
00:00 Intro
00:30 Breaking barriers in cancer care
12:46 RBI pulls the plug on Simpl
20:44 Tidbits

Get smarter every day with our daily newsletter. Subscribe here: https://thedailybrief.zerodha.com/

Checkout The Chatter here: https://thechatterbyzerodha.substack....

Check out our latest newsletter "Aftermarket Report" here: https://aftermarketreport.substack.com/

Every day, each team member shares something they've learned, not limited to finance. It's our way of trying to be a little less dumb every day. Check it out here: https://onethingwelearned.today/

Listen to this episode on your preferred podcast platform:

Spotify: https://open.spotify.com/show/2SJiLdv...

Apple Podcasts: https://podcasts.apple.com/in/podcast...


Disclaimer: Some image(s) may have been created using Al, no copyright infringement is intended.

Note: This content is for informational purposes only. None of the stocks, brands or products mentioned are recommendations or endorsements.